1.
|
Phase: Phase III, Phase II
Type: Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 001-0015-211, NCT00127387
|
|
2.
|
Phase: Phase III
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2005-0901, NCT00513357
|
|
3.
|
Phase: Phase II
Type: Supportive care
Status: Active
Age: 18 to 80
Sponsor: Pharmaceutical / Industry
Protocol IDs: AVR118 04-002, NCT00127517
|
|
4.
|
Phase: Phase II
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2005-0816, NCT00489307
|
|
5.
|
Phase: Phase II
Type: Supportive care
Status: Active
Age: 25 to 80
Sponsor: Other
Protocol IDs: MCC-15190, IRB 105759c, NCT00815685
|
|
6.
|
Phase: Phase II
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: INST 0816, NCT00832520
|
|
7.
|
Phase: Phase I
Type: Supportive care
Status: Active
Age: Not specified
Sponsor: Other
Protocol IDs: 2005-0620, NCT00489593
|
|
8.
|
Phase: Phase I
Type: Biomarker/Laboratory analysis, Supportive care
Status: Active
Age: 18 to 59
Sponsor: NCI
Protocol IDs: UTMB-06073, IRB#06-073, GCRC#724, NCT00878995
|
|
9.
|
Phase: No phase specified
Type: Supportive care
Status: Active
Age: Over 18
Sponsor: Other
Protocol IDs: 2005-0916, NCT00488072
|
|
10.
|
Phase: No phase specified
Type: Supportive care
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: 2006-0739, NCT00625742
|
|
11.
|
Phase: No phase specified
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 08-0132, NCT00727376
|
